A list of antiretrovirals and other select medications available through the BC-CfE’s HIV Treatment Program is available in the PDF document (above). These medications can be requested by submitting an HIV Treatment Prescription Request Form found here. Requests will be assessed according to the BC-CfE therapeutic guidelines. Clinical justification and/or supportive documentation may be required. Eligible individuals will obtain, at no cost, medications offered through the BC-CfE’s Drug Treatment Program.
A request for restricted, or non-BC-CfE formulary medications, may be submitted with full documentation supporting the request.
These will be subject to clinical review on a case-by-case basis, for consideration of exceptional coverage.
Additional Guidance:
- Cabotegravir plus rilpivirine (PrCabenuva) in PLWH with viremia (June 2024)
- Guideline for Antiretroviral Therapy (ART) Regimens for Initial Therapy and for Switching ART in Virologically Stable Suppressed Adults
- DTP Communications: Guidance on cabotegravir-rilpivirine extended-release injectable suspensions (Cabenuva®)
- Cabotegravir & Rilpivirine Long-Acting Injections – A Primer (Video):